Clinical Trial Update: Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind study evaluating pregabalin for pain associated with diabetic neuropathy has completed with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Painful Diabetic Neuropathy

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Diabetic Neuropathy, Painful | Phase 3 | Status: COMPLETED | Results posted: 2010-06-22